|
Metabolic syndrome
(n=276) |
Control
(n=335) |
p |
Age, years |
56.8 ± 12.2 |
55.6 ± 12.9 |
0.26 |
Male, n (%) |
210 (76%) |
311 (92%) |
0.01 |
Height, (m) |
1.69 ± 0.08 |
1.71 ± 0.06 |
0.07 |
Weight, (kg) |
84.8 ± 13.9 |
77.2 ± 12.2 |
0.01 |
BMI, kg/m2 |
29.4 ± 4.5 |
26.2 ± 3.6 |
0.01 |
Smoking, n (%) |
181 (66%) |
273 (81%) |
0.01 |
Hyperlipidemia, n (%) |
87 (32%) |
55 (16%) |
0.01 |
Family history of CAD, n (%) |
100 (36%) |
91 (27%) |
0.02 |
Prior myocardial infarction, n (%) |
30 (11%) |
28 (8%) |
0.62 |
Systolic blood pressure, mmHg |
125 ± 25 |
123 ± 24 |
0.15 |
Diastolic blood pressure, mmHg |
76 ± 15 |
74 ± 14 |
0.33 |
Killip class >1, n (%) |
15 (5%) |
23 (7%) |
0.46 |
Anterior myocardial infarction, n (%) |
130 (47%) |
165 (49%) |
0.59 |
Reperfusion time, min |
210 ± 130 |
215 ± 145 |
0.69 |
Post PCI TIMI 3 flow, n (%) |
266 (96%) |
330 (99%) |
0.09 |
Left ventricular EF, % |
45.1 ± 8.6 |
46.1 ± 8.2 |
0.13 |
Components of metabolic syndrome |
|
|
|
Diabetes mellitus or fasting
glucose > 100 mg/dL, n (%) |
234 (85%) |
77 (23%) |
0.01 |
Hypertension, n (%) |
184 (67%) |
63 (19%) |
0.01 |
Waist circumference, cm |
95.4 ± 12.2 |
88.3 ± 10.1 |
0.01 |
HDL, cholesterol, mg/dL |
37.3 ± 9.9 |
40.9 ± 11.3 |
0.01 |
Triglycerides, mg/dL |
181 (98) |
111 (60) |
0.01 |
Fasting glucose level, mg/dL |
121 (47) |
101 (28) |
0.01 |
Laboratory findings |
|
|
|
Creatinine, mg/dL |
0.92 ± 0.37 |
0.87 ± 0.28 |
0.08 |
Peak CK-MB, U/L |
128 (140) |
143 (181) |
0.12 |
Hemoglobin, g/dL |
14.1 ± 2.4 |
14.2 ± 1.6 |
0.48 |
Platelet, 103 /µL |
254 ± 79 |
247 ± 72 |
0.22 |
Total cholesterol, mg/dL |
184 (55) |
195 (57) |
0.11 |
LDL, cholesterol, mg/dL |
124.8 ± -37.3 |
117.9 ± 36.7 |
0.04 |
Parametric variables are reported in mean ± SD or median (inter-quantile range); categorical variables are reported in number (percentage); BMI: Body Mass Index, CAD:
Coronary Artery Disease, Post-PCI: Post-primary Coronary Intervention, EF: Ejection Fraction, HDL: High Density Lipoprotein, LDL: Low Density Lipoprotein |